Kabir A, Bukar M, Nggada HA, Rann HB, Gidado A, Musa AB. Prevalence of human papillomavirus genotypes in cervical cancer in Maiduguri, Nigeria. Pan Afr Med J. 2019;33:284.

Article  PubMed  PubMed Central  Google Scholar 

Bruni LAG, Serrano B, Mena M, Collado JJ, Gómez D, Muñoz J, et al. Human Papillomavirus and Related Diseases in the World. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre); 2023.

Google Scholar 

Steben M, Duarte-Franco E. Human papillomavirus infection: epidemiology and pathophysiology. Gynecol Oncol. 2007;107(2):S2–5.

Article  CAS  PubMed  Google Scholar 

Attoh S, Asmah R, Wiredu E, Gyasi R, Tettey Y. Human papilloma virus genotypes in Ghanaian women with cervical carcinoma. East Afr Med J. 2010;87(8).

de Sanjose S, Brotons M, Pavon MA. The natural history of human papillomavirus infection. Best Pract Res Clin Obstet Gynaecol. 2018;47:2–13.

Article  PubMed  Google Scholar 

Farahmand M, Moghoofei M, Dorost A, Abbasi S, Monavari SH, Kiani SJ, et al. Prevalence and genotype distribution of genital human papillomavirus infection in female sex workers in the world: a systematic review and meta-analysis. BMC Public Health. 2020;20(1):1–14.

Article  Google Scholar 

Wall SR, Scherf CF, Morison L, Hart KW, West B, Ekpo G, et al. Cervical human papillomavirus infection and squamous intraepithelial lesions in rural Gambia, West Africa: viral sequence analysis and epidemiology. Br J Cancer. 2005;93(9):1068–76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dareng EO, Adebamowo SN, Famooto A, Olawande O, Odutola MK, Olaniyan Y, et al. Prevalence and incidence of genital warts and cervical Human Papillomavirus infections in Nigerian women. BMC Infect Dis. 2019;19(1):27.

Article  PubMed  PubMed Central  Google Scholar 

Ogembo RK, Gona PN, Seymour AJ, Park HS-M, Bain PA, Maranda L, et al. Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysis. PLoS One. 2015;10(4):e0122488.

Article  PubMed  PubMed Central  Google Scholar 

Joura EA, Ault KA, Bosch FX, Brown D, Cuzick J, Ferris D, et al. Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease. Cancer Epidemiol Biomark Prev. 2014;23(10):1997–2008.

Article  Google Scholar 

Mujuni F, Mirambo MM, Rambau P, Klaus K, Andreas M, Matovelo D, et al. Variability of high risk HPV genotypes among HIV infected women in Mwanza, Tanzania-the need for evaluation of current vaccine effectiveness in developing countries. Infect Agents Cancer. 2016;11:1–7.

Article  Google Scholar 

Nartey Y, Amo-Antwi K, Hill PC, Dassah ET, Asmah RH, Nyarko KM, et al. Human papillomavirus genotype distribution among women with and without cervical cancer: Implication for vaccination and screening in Ghana. PLoS One. 2023;18(1):e0280437.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Krings A, Dunyo P, Pesic A, Tetteh S, Hansen B, Gedzah I, et al. Characterization of Human Papillomavirus prevalence and risk factors to guide cervical cancer screening in the North Tongu District, Ghana. PLoS One. 2019;14(6):e0218762.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nejo Y, Olaleye D, Odaibo G. Prevalence and risk factors for genital human papillomavirus infections among women in Southwest Nigeria. Arch Basic Appl Med. 2018;6(1):105.

CAS  PubMed  PubMed Central  Google Scholar 

Ogah J, Kolawole O, Awelimobor D. High risk human papilloma virus (HPV) common among a cohort of women with female genital mutilation. Afr Health Sci. 2019;19(4):2985–92.

Article  PubMed  PubMed Central  Google Scholar 

Capo-Chichi CD, Aguida B, Chabi NW, Acapko-Ezin J, Sossah-Hiffo J, Agossou VK, et al. Diversity of high risk human papilloma viruses in women treated with antiretroviral and in healthy controls and discordance with cervical dysplasia in the South of Benin. Infect Agent Cancer. 2016;11:43.

Article  PubMed  PubMed Central  Google Scholar 

Ouedraogo CM, Djigma FW, Bisseye C, Sagna T, Zeba M, Ouermi D, et al. Epidemiology, characterization of genotypes of human papillomavirus in a population of women in Ouagadougou. J Gynecol Obstet Biol Reprod (Paris). 2011;40(7):633–8.

Article  CAS  PubMed  Google Scholar 

Ouattara S, Somé DA, Dembélé A, Sanfo S, Zohoncon T, Ouattara A-K, et al. Molecular Epidemiology of High-Risk Human Papilloma Virus Infection in Sexually Active Women at Bobo-Dioulasso University Teaching Hospital. Open Obstet Gynecol. 2019;9(8):1178–88.

Article  Google Scholar 

Zohoncon T, Djigma F, Ouattara A, Traore I, Ouedraogo R, Traore E, et al. Mapping of fourteen high-risk human papillomavirus genotypes by molecular detection in sexually active women in the West African sub-region. Int J Genet Mol Biol. 2020;12(1):11–21.

CAS  Google Scholar 

Mirabello L, Yeager M, Cullen M, Boland JF, Chen Z, Wentzensen N, et al. HPV16 sublineage associations with histology-specific cancer risk using HPV whole-genome sequences in 3200 women. JNCI: J Natl Cancer Inst. 2016;108(9):djw100.

Article  PubMed  PubMed Central  Google Scholar 

Clifford GM, Gallus S, Herrero R, Muñoz N, Snijders PJ, Vaccarella S, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet (London, England). 2005;366(9490):991–8.

Article  CAS  PubMed  Google Scholar 

Derkay CS, Wiatrak B. Recurrent respiratory papillomatosis: a review. Laryngoscope. 2008;118(7):1236–47.

Article  PubMed  Google Scholar 

Ilboudo M, Zohoncon TM, Traore IMA, Traore EMA, Kande A, Obiri-Yeboah D, et al. Implication of low risk human papillomaviruses, HPV6 and HPV11 in laryngeal papillomatosis in Burkina Faso. Am J Otolaryngol. 2019;40(3):368–71.

Article  PubMed  Google Scholar 

Seyoum A, Assefa N, Gure T, Seyoum B, Mulu A, Mihret A. Prevalence and genotype distribution of high-risk human papillomavirus infection among Sub-Saharan African women: a systematic review and meta-analysis. Front Public Health. 2022;10:890880.

Article  PubMed  PubMed Central  Google Scholar 

Keita N, Clifford G, Koulibaly M, Douno K, Kabba I, Haba M, et al. HPV infection in women with and without cervical cancer in Conakry. Guinea Br J Cancer. 2009;101(1):202–8.

Article  CAS  PubMed  Google Scholar 

Debrah O, Agyemang-Yeboah F, Donkoh ET, Asmah RH. Prevalence of vaccine and non-vaccine human papillomavirus types among women in Accra and Kumasi, Ghana: a cross-sectional study. BMC Womens Health. 2021;21(1):372.

Article  PubMed  PubMed Central  Google Scholar 

Donkoh ET, Asmah RH, Agyemang-Yeboah F, Dabo EO, Wiredu EK. Prevalence and Distribution of Vaccine-Preventable Genital Human Papillomavirus(HPV) Genotypes in Ghanaian Women Presenting for Screening. Cancer Control. 2022;29:10732748221094721.

Article  PubMed  PubMed Central  Google Scholar 

Organization WH. Human papillomavirus vaccines : WHO position paper, May 2017. Wkly Epidemiol Rec= Relevé Épidémiol Hebdomadaire. 2017;92(19):241–68.

Google Scholar 

Clifford GM, Goncalves MAG, Franceschi S, HPV, group Hs. Human papillomavirus types among women infected with HIV: a meta-analysis. Aids. 2006;20(18):2337–44.

Article  PubMed  Google Scholar 

De Vuyst H, Alemany L, Lacey C, Chibwesha CJ, Sahasrabuddhe V, Banura C, et al. The burden of human papillomavirus infections and related diseases in sub-saharan Africa. Vaccine. 2013;31:F32–46.

Article  PubMed  PubMed Central  Google Scholar 

De Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664–70.

Article  PubMed  PubMed Central  Google Scholar 

Munoz N, Bosch FX, Castellsagué X, Díaz M, De Sanjose S, Hammouda D, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer. 2004;111(2):278–85.

Article  CAS  PubMed  Google Scholar 

De Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048–56.

Article  PubMed  Google Scholar 

Mejilla A, Li E, Sadowski CA. Human papilloma virus (HPV) vaccination: questions and answers. Can Pharm J/Revue des Pharmaciens du Canada. 2017;150(5):306–15.

Article  Google Scholar 

Fokom-Domgue J, Combescure C, Fokom-Defo V, Tebeu PM, Vassilakos P, Kengne AP, et al. Performance of alternative strategies for primary cervical cancer screening in sub-Saharan Africa: systematic review and meta-analysis of diagnostic test accuracy studies. Bmj. 2015;351.

Wright TC Jr, Kuhn L. Alternative approaches to cervical cancer screening for developing countries. Best Pract Res Clin Obstet Gynaecol. 2012;26(2):197–208.

Article  PubMed  Google Scholar 

Moher D, Liberati A, Tetzlaff J, Altman DG, Group* P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9.

Article  PubMed  Google Scholar 

Okolo C, Franceschi S, Adewole I, Thomas JO, Follen M, Snijders PJ, et al. Human papillomavirus infection in women with and without cervical cancer in Ibadan, Nigeria. Infect Agent Cancer. 2010;5(1):24.

Article  PubMed  PubMed Central  Google Scholar 

Institute JB. Joanna Briggs Institute reviewers’ manual: 2014 edition. Australia: The Joanna Briggs Institute; 2014. p. 88–91.

Google Scholar 

Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. JBI Evid Implement. 2015;13(3):147–53.

Google Scholar 

Modibbo F, Iregbu KC, Okuma J, Leeman A, Kasius A, de Koning M, et al. Randomized trial evaluating self-sa